A Note from Dr. Robert Stout, CRL Chief Scientific Officer & Co-Founder The below commentary from Michael Fulks, MD, is… Read More
Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Michael Fulks comments on the results of a recent study of Donanemab, an antibody that targets the amyloid-β (Aβ)… Read More
Dr. Michael Fulks is a Medical Director for Clinical Reference Laboratory (CRL). He is an expert commentator on core issues… Read More